ATTRv is a systemic amyloidosis with autosomal dominant transmission characterized by a genetic mutation of TTR, of which more than 150 variants have been identified, the majority of which are amino acid pathogenic variants due to a nucleotide substitution [55,65]. Here, TTR is linked to primary systemic amyloidosis.